*Most common type of pemphigus, typically affecting interior of the mouth
*Autoimmune disorder which destroys connectivity of skin cells
*Consists of small easily ruptured blisters which leave behind erosions, crusting, and inflammation
Pemphigus vulgaris is the most common type of pemphigus which typically affects interior of the mouth, but may occur in other mucosa or on the skin. The condition consists of the formation of small, easily ruptured blisters. Ruptured blisters leave behind skin erosions which may crust and become red and inflamed. This may be accompanied by burning or pain in the affected area.
Pemphigus vulgaris is an autoimmune disorder in which the immune system destroys the connective tissue that holds skin cells together, causing blistering. The condition may affect any age, gender or ethnic group, but typically appears between 50-60 years of age.
Differential Diagnosis (Other conditions with similar appearance)
Drug-Induced Bullous Disorders
Pemphigus (various forms)
Epidermolysis bullosa Acquisita
Subcorneal pustular dermatosis
Linear IgA dermatosis
*Diagnosis based on skin biopsy of the affected area
*Staining will be performed to confirm the condition
Pemphigus vulgaris is typically diagnosed based on a skin biopsy of the affected area, and confirmed by a stain of the affected tissue. These tests will also rule out similar appearing conditions.
*There is no effective cure for the condition
*Goal of treatment is to lessen the formation of new lesions and prevent infection
*Treatment typically consists of oral corticosteroids and/or immunosuppressants
There is no cure for pemphigus vulgaris. The goal of treatment is to lessen the formation of new lesions, promote healing in affected areas, and to prevent secondary infection. Oral corticosteroids are typically used in treatment, though prolonged usage and high doses carry serious risks. To reduce use of these steroids, other immunosuppressant medications are prescribed, such as azathioprine, cyclophosphamide, dapson, tetracyclines, plasmapheresis, nicotinamide, Mycophenolate mofetil, IV Immunoglobulin, gold, Infliximab, and rituximab. Proper wound care is recommended to prevent secondary infections and help encourage resolution. Affected persons will often see moderate symptoms under treatment, and it is recommended that any activity which may cause injury to the affected areas be avoided.